168
Participants
Start Date
November 30, 2015
Primary Completion Date
February 21, 2017
Study Completion Date
February 24, 2017
CRD007
Placebo
First MHAT - Sofia EAD, Third Department of Internal Medicine, Sofia
MHAT Lyulin EAD, Department of Internal Medicine, Sofia
Bisbebjerg Hospital, København NV
MHAT St. Ivan Rilski-2003 Ltd., Department of Internal Medicine, Dupnitsa
Hvidovre Hospital, Hvidovre
SHATPPD Vratsa Ltd, Department of Pneumology, Vratsa
SHATPPD - Pazardzhik EOOD, Department of phthisiatrics pneumonia and pulmonary functional diagnostics, Pazardzhik
Medical Center Smolyan OOD, Office of Clinical Allergology, Smolyan
Næstved Sygehus, Lungemedinsk afdeling, Næstved
Medical Center - Razgrad OOD, Office of Pneumonology and Phthisiatry, Razgrad
Regionshospitalet Silkeborg, Silkeborg
Aalborg Universitetshospital, Aalborg
Centrum Badań Klinicznych PI-House Sp. Z O.O., Gdansk
Medica Pro Familia, Katowice
NZOZ Centrum Medcyczne ProMiMed, Krakow
Medica Pro Familia, Krákow
Clinical Best Solution, Lublin
NZOZ ALERGO-MED. Specjalistyczna Przychodnia Lekarska, Poznan
Medica Pro Familia, Warsaw
Centrum Medyczne Oporów, Wroclaw
The Medicines Evaluation Unit (MEU) Ltd, Manchester
Medinova North London Clinical Studies Center, Northwood
Medinova East London Clinical Studies Centre, Romford
Medinova South London Clinical Studies Centre, Sidcup
RSPR Pharma AB
INDUSTRY